AU2002366042A1 - Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations - Google Patents

Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations

Info

Publication number
AU2002366042A1
AU2002366042A1 AU2002366042A AU2002366042A AU2002366042A1 AU 2002366042 A1 AU2002366042 A1 AU 2002366042A1 AU 2002366042 A AU2002366042 A AU 2002366042A AU 2002366042 A AU2002366042 A AU 2002366042A AU 2002366042 A1 AU2002366042 A1 AU 2002366042A1
Authority
AU
Australia
Prior art keywords
preparations
solid dispersions
insoluble drug
dispersions containing
containing substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366042A
Inventor
Si-Young Chang
Jae-Shin Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA DDS PHARMACEUTICAL CO Ltd
Original Assignee
DDS TECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DDS TECH CO Ltd filed Critical DDS TECH CO Ltd
Publication of AU2002366042A1 publication Critical patent/AU2002366042A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002366042A 2001-11-20 2002-11-18 Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations Abandoned AU2002366042A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2001/72412 2001-11-20
KR1020010072412A KR20030041577A (en) 2001-11-20 2001-11-20 Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations
PCT/KR2002/002151 WO2003043602A1 (en) 2001-11-20 2002-11-18 Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations

Publications (1)

Publication Number Publication Date
AU2002366042A1 true AU2002366042A1 (en) 2003-06-10

Family

ID=19716122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366042A Abandoned AU2002366042A1 (en) 2001-11-20 2002-11-18 Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations

Country Status (3)

Country Link
KR (1) KR20030041577A (en)
AU (1) AU2002366042A1 (en)
WO (1) WO2003043602A1 (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259153B2 (en) * 2003-02-03 2007-08-21 Supernus Pharmaceuticals Drug formulation and delivery using crystalline methylated cyclodextrins
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
KR100567131B1 (en) * 2004-01-05 2006-04-05 신일제약주식회사 Taste masking of oral ibuprofen and arginine solution
CZ2004262A3 (en) * 2004-02-20 2005-06-15 I. Q. A., A. S. Stable, taste-acceptable syrups containing ibuprofen and process of their preparation
KR20050105565A (en) * 2004-04-30 2005-11-04 에스케이케미칼주식회사 Stable pharmaceutical composition containing benzimidazole compounds and method of manufacturing the same
DE602005027092D1 (en) * 2004-08-02 2011-05-05 Chiesi Farma Spa PROCESS FOR PREPARING A PIROXICAM: BETA-CYCLODEXTRIN INCLUSION COMPOUND
US20060105045A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Cyclodextrin solubilizers for liquid and semi-solid formulations
KR100678824B1 (en) * 2005-02-04 2007-02-05 한미약품 주식회사 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same
WO2007031933A2 (en) * 2005-09-12 2007-03-22 Actelion Pharmaceuticals Ltd Stable pharmaceutical composition comprising a pyrimidine-sulfamide
RU2455996C2 (en) * 2005-09-30 2012-07-20 Лундбек Инк. New parenteral carmabazepine composition
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
KR100726720B1 (en) * 2005-12-26 2007-06-11 코스맥스 주식회사 Nano capsule liposome composition double-stabilized water insoluble active material by hydroxy alkylated cyclodextrin and liposome
KR100809046B1 (en) * 2006-03-10 2008-03-03 가톨릭대학교 산학협력단 Self assembled nanoparticle having pullulan and methods of using thereof
US20070238942A1 (en) * 2006-04-10 2007-10-11 Esophamet Corp. Apparatus and method for detecting gastroesophageal reflux disease (gerd)
KR100917809B1 (en) 2006-05-22 2009-09-18 에스케이케미칼주식회사 Stable Pharmaceutical Composition containing Docetaxel
WO2007141806A1 (en) * 2006-06-02 2007-12-13 Jubilant Organosys Ltd Pharmaceutical formulations comprising oxcarbazepine and methods thereof
KR100917810B1 (en) * 2006-06-02 2009-09-18 에스케이케미칼주식회사 Stable Pharmaceutical Composition containing Paclitaxel
CN100411688C (en) 2006-09-12 2008-08-20 南京师范大学 Medicine composition containing cyclodextrin/polyene taxol and its prepn process
CN100486645C (en) * 2006-09-12 2009-05-13 南京师范大学 Medicine composition containing cyclodextrin included taxol and its preparation process
KR100822133B1 (en) * 2006-11-06 2008-04-15 한미약품 주식회사 Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate
WO2008092046A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Amorphous oxcarbazepine and the production thereof
WO2009007996A2 (en) * 2007-04-27 2009-01-15 Sun Pharmaceutical Industries Limited Cyclodextrin complexes of atovaquone
ITMI20071502A1 (en) 2007-07-25 2009-01-26 Archimica Srl PROCEDURE FOR THE PREPARATION OF SOLID RELEVANT CONTROLLED FORMULATIONS CONTAINING OXCARBAZEPINE AND FORMULATIONS OBTAINED BY THIS PROCEDURE
MX2010001837A (en) 2007-08-17 2010-03-10 Actelion Pharmaceuticals Ltd Iron with actively cooled soleplate and method for cooling the soleplate.
CL2007003877A1 (en) * 2007-12-28 2008-06-27 Univ De Concepcion Lab Androma PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INCLUSION COMPLEX FORMED BY DISULFIRAM AND A CYCLODEXTRINE; AND ITS USE FOR THE TREATMENT OF THE ALCOHOL AND COCAINE DEPENDENCE.
CL2007003876A1 (en) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro INCLUSION COMPLEX THAT IS FORMED BY DISULFIRAM AND CYCLODEXTRINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF THE ALCOHOL AND COCAINE DEPENDENCE.
US9119819B2 (en) * 2008-04-30 2015-09-01 Wockhardt Ltd. Oral liquid compositions of rhein or diacerein
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN102458114A (en) 2009-05-29 2012-05-16 锡德克斯药物公司 Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
WO2010150144A2 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Low dose pharmaceutical compositions of celecoxib
CN102008470B (en) * 2010-05-24 2012-08-29 中国人民解放军第二军医大学 Compound preparation and use thereof for preventing and treating noise induced hearing damage
NZ604498A (en) * 2010-05-26 2014-10-31 Neurophyxia B V 2-iminobiotin formulations and uses thereof
CN101953837B (en) * 2010-09-20 2012-04-18 山西康宝生物制品股份有限公司 Felodipine sustained-release tablets and preparation method thereof
WO2013089479A1 (en) * 2011-12-15 2013-06-20 주식회사 삼양바이오팜 Solid dispersion containing celecoxib, and method for preparing same
CN102579395B (en) * 2012-03-30 2013-10-30 江苏万禾制药有限公司 Lipoic acid capsules as well as preparation process and application thereof
CN103142499B (en) * 2013-03-21 2014-10-01 青岛正大海尔制药有限公司 Etoposide particle
MX348595B (en) 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Pharmaceutical composition with anti-inflammatory agents and production process thereof.
CN103690504B (en) * 2013-12-18 2018-03-30 北京华禧联合科技发展有限公司 A kind of preparation method of rosuvastatin calcium tablets solid dispersions
EP3110402A1 (en) * 2014-02-28 2017-01-04 Sun Pharmaceutical Industries Ltd Dapagliflozin compositions
CA2941632C (en) * 2014-03-13 2023-10-24 Vasilios VOUDOURIS Bendamustine solid dispersions and continuous infusion
WO2015152433A1 (en) 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
CN103948550A (en) * 2014-04-22 2014-07-30 青岛市市立医院 Cisapride dispersible tablet and preparation method thereof
JP6203702B2 (en) * 2014-11-18 2017-09-27 信越化学工業株式会社 Solution for spray drying using hypromellose acetate succinate and method for producing solid dispersion
CN104523615B (en) * 2014-12-12 2017-07-04 常州康普药业有限公司 A kind of Sulpiride tablet and preparation method thereof
CN108348560A (en) 2015-03-19 2018-07-31 锡德克斯药物公司 Include the composition and its application method of silymarin and sulphur hydrocarbyl ether cyclodextrin
CN105106161B (en) * 2015-09-11 2017-10-24 苏州东瑞制药有限公司 A kind of Levamlodipine beaylate tablets and its preparation technology
CN105832680B (en) * 2016-05-12 2018-12-25 沈阳药科大学 A kind of pharmaceutical composition improving spirolactone In Vitro Dissolution and mobility
CN106309373A (en) * 2016-09-21 2017-01-11 沈阳药科大学 Probucol solid dispersion and preparation method thereof
CN107751576A (en) * 2017-11-13 2018-03-06 厦门大学 A kind of B B-complex liquid and preparation method thereof
RU2692772C2 (en) * 2017-11-15 2019-06-27 Общество с ограниченной ответственностью "Технофарм" Composition and method for preparing rapidly soluble antifungal drug based on nitrofural
CN108379229A (en) * 2018-04-05 2018-08-10 孙金霞 A kind of anti-inflammatory Claritin solid dispersion composition and preparation method thereof
CN109044967B (en) * 2018-10-17 2021-02-02 江苏领航生物科技有限公司 Teniposide injection solution with good dilution stability and preparation method thereof
US20210338702A1 (en) * 2018-10-17 2021-11-04 Jiangsu Linghang Biological Technology Co., Ltd. A teniposide injection with high dilution stability and preparation method thereof
RU2712123C1 (en) * 2018-12-14 2020-01-27 Общество с ограниченной ответственностью "Технофарм" Composition and method for preparing a rapidly soluble antimicrobial drug based on nitrofural (versions)
CN109864971B (en) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 Granules of lamotrigine solid dispersion and preparation method thereof
WO2021040440A1 (en) * 2019-08-30 2021-03-04 (주)셀트리온 Pharmaceutical composition for treating or preventing nonalcoholic steatohepatitis (nash)
CN110652496A (en) * 2019-11-11 2020-01-07 中山大学 Solid dispersion of cryptotanshinone and preparation method and application thereof
CN111529497A (en) * 2020-02-11 2020-08-14 兆科（广州）肿瘤药物有限公司 Gemastecan drug solid dispersion composition and preparation method thereof
CN114831951B (en) * 2022-04-25 2023-10-03 扬子江药业集团广州海瑞药业有限公司 Ezetimibe tablet and preparation method thereof
CN116059399B (en) * 2023-01-06 2024-07-26 山东华农生物制药有限公司 Method for coating bighead atractylodes rhizome oil by combining solid dispersion and ultrasonic method
CN116159034B (en) * 2023-04-23 2023-07-04 国药集团川抗制药有限公司 Tacrolimus sustained-release capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
KR100211222B1 (en) * 1996-01-18 1999-07-15 이범진 Site-specific release preparation containing inclusion complex
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations

Also Published As

Publication number Publication date
KR20030041577A (en) 2003-05-27
WO2003043602A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AU2002366042A1 (en) Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
HK1079215A1 (en) 17 alpfa-alkyl-17beta-oxy-estrqatrienes, uses thereof and pharmaceutical preparations
AU2002341959A1 (en) Drug delivery devices and methods
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2002309172A1 (en) Pharmaceutical compositions containing polymer and drug assemblies
AU2001252956A1 (en) Syndication loan administration and processing system
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
HK1068812A1 (en) Drug preparations
AU2002358653A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
AU4328800A (en) Pharmaceutical formulation
AU2002361036A1 (en) Cosmetic and/or pharmaceutical emulsions
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU2002219330A1 (en) Activatable cytolytic or drug delivery peptides and uses thereof
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2001247793A1 (en) Financial product administration system and methods
AU3839900A (en) Pharmaceutical formulation
AU1172101A (en) Phytoestrogenic pharmaceutical preparations
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2002332286A1 (en) Water-soluble phenylpyridazine derivatives and medicines containing the same
AU4504201A (en) Drug preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase